People In The News: Tracking The Latest Industry Personnel Moves
Executive Summary
New top leadership at PPD and Promedior; Pfizer names new presidents at two business units; Former FDA Commissioner von Eschenbach and former HHS Secretary Thompson take on board of director roles. More personnel announcements in this month’s column.
You may also be interested in...
Pfizer Shuffle: Simmons Out, Brandicourt In At Emerging Markets And Established Products Unit
David Simmons, head of established products and emerging markets at Pfizer, has jumped ship to lead global CRO PPD Inc. Olivier Brandicourt, currently head of primary care at the big pharma, will take Simmons’ place.
Finance Watch: Adlai Nortye Raises $97.5m In IPO, Brings US Total To 18
Public Company Edition: Cancer-focused Adlai Nortye launched a concurrent initial public offering and private placement, while four other drug developers announced or completed SPAC mergers. Also, Sobi grossed $540m in a rights issue and Immunovant followed early data with a $450m FOPO.
Amicus Piggybacks Off Galafold Commercial Infrastructure For Pombiliti + Opfolda Launch
The company anticipates potential sales in excess of $1bn for the late-onset Pompe disease drug by the end of the decade.